Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2423 in painful diabetic polyneuropathy
NCT01201317Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of azd2423 in diabetic polyneuropathy (DPN), sponsored by AstraZeneca. Started Sep 2010; status: completed.
02
Drugs
azd2423
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT01201317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01201317.